EP1117998A1 - Egfr 37 kda fragment as cancer marker - Google Patents
Egfr 37 kda fragment as cancer markerInfo
- Publication number
- EP1117998A1 EP1117998A1 EP99947700A EP99947700A EP1117998A1 EP 1117998 A1 EP1117998 A1 EP 1117998A1 EP 99947700 A EP99947700 A EP 99947700A EP 99947700 A EP99947700 A EP 99947700A EP 1117998 A1 EP1117998 A1 EP 1117998A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- egfr
- 37kda
- fragment
- test
- patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9821170 | 1998-09-30 | ||
GBGB9821170.9A GB9821170D0 (en) | 1998-09-30 | 1998-09-30 | Marker |
PCT/GB1999/003235 WO2000019208A1 (en) | 1998-09-30 | 1999-09-30 | Egfr 37 kda fragment as cancer marker |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1117998A1 true EP1117998A1 (en) | 2001-07-25 |
Family
ID=10839659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99947700A Withdrawn EP1117998A1 (en) | 1998-09-30 | 1999-09-30 | Egfr 37 kda fragment as cancer marker |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1117998A1 (en) |
AU (1) | AU6107699A (en) |
GB (1) | GB9821170D0 (en) |
WO (1) | WO2000019208A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2320549A1 (en) * | 2000-09-25 | 2002-03-25 | Eastern Virginia Medical College | Biomarkers of transitional cell carcinoma of the bladder |
GB2424070B (en) * | 2002-11-14 | 2007-06-27 | Univ Nottingham | Methods for preparing tumour marker proteins |
WO2006074360A2 (en) | 2005-01-06 | 2006-07-13 | Eastern Virginia Medical School | Apolipoprotein a-ii isoform as a biomarker for prostate cancer |
EP3224627A1 (en) * | 2014-11-28 | 2017-10-04 | The University Of Birmingham | Bladder cancer prognosis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3934085A (en) * | 1984-01-30 | 1985-08-09 | Icrf Patents Ltd. | Improvements relating to growth factors |
AU2178292A (en) * | 1991-06-03 | 1993-01-08 | Triton Diagnostics, Inc. | Epidermal growth factor receptor ectodomain |
-
1998
- 1998-09-30 GB GBGB9821170.9A patent/GB9821170D0/en not_active Ceased
-
1999
- 1999-09-30 AU AU61076/99A patent/AU6107699A/en not_active Abandoned
- 1999-09-30 WO PCT/GB1999/003235 patent/WO2000019208A1/en not_active Application Discontinuation
- 1999-09-30 EP EP99947700A patent/EP1117998A1/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO0019208A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU6107699A (en) | 2000-04-17 |
GB9821170D0 (en) | 1998-11-25 |
WO2000019208A1 (en) | 2000-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6630766B2 (en) | Pancreatic cancer diagnostic composition and pancreatic cancer diagnostic method using the same | |
US20110251097A1 (en) | Diagnostic kit of colon cancer using colon cancer related marker and diagnostic method thereof | |
US10139412B2 (en) | Semaphorin 3A as a diagnostic marker for urothelial cancer | |
JP2002515262A (en) | Novel method for diagnosing, monitoring and staging lung cancer | |
CN112345755A (en) | Biomarker of breast cancer and application thereof | |
Kim et al. | Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer | |
US20120295288A1 (en) | Serological marker for detecting pancreatic cancer and a method for using the serological marker | |
CN109313192B (en) | Use of nucleosome-transcription factor complexes for cancer detection | |
KR20110076829A (en) | Complement c9 as markers for the diagnosis of cancer | |
Wang et al. | The significance of biomarkers in nipple discharge and serum in diagnosis of breast cancer | |
WO2000019208A1 (en) | Egfr 37 kda fragment as cancer marker | |
CN112334487B (en) | Compositions and methods for diagnosing and treating cancer | |
CN109116023A (en) | A kind of lung cancer marker anti-MM P12 autoantibody and its application | |
Abdel-Aziz et al. | Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor | |
JP3524876B2 (en) | Use of PLA2 as a metastatic marker and for the diagnosis of certain cancers | |
KR20110076830A (en) | Complement c9 as markers for the diagnosis of small cell lung cancer and non-small cell lung cancer | |
CN110736840A (en) | Application of MMP7, CTSE or LAMC2 protein in preparation of intrahepatic cholangiocellular carcinoma diagnostic reagent | |
KR20210109724A (en) | A Composition for Diagnosing Cancer | |
Moroz et al. | FBL blood test as a predictive marker of breast cancer in high risk women | |
KR102280360B1 (en) | A Composition for Diagnosing Cancer | |
KR102325742B1 (en) | A Composition for Diagnosing Cancer | |
KR102316892B1 (en) | A Composition for Diagnosing Cancer | |
US20230341403A1 (en) | Methods and kits for the diagnosis of lung cancer | |
KR100983386B1 (en) | Novel use of AGR-2 for diagnosing ovarian carcinoma | |
US20150004621A1 (en) | Biological marker for early cancer detection and methods for cancer detection (bf819) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010419 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: UUTECH LIMITED |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: UUTECH LIMITED |
|
17Q | First examination report despatched |
Effective date: 20050510 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20050401 |